PROPRANOLOL HYDROCHLORIDE Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Propranolol Hydrochloride, and what generic alternatives are available?
Propranolol Hydrochloride is a drug marketed by Actavis Elizabeth, Adare Pharms Inc, Amta, Inwood Labs, Lupin Ltd, Nortec Dev Assoc, Rising, Upsher Smith Labs, Zydus Pharms Usa Inc, Baxter Hlthcare Corp, Chartwell Injectable, Fosun Pharma, Fresenius Kabi Usa, Hikma Farmaceutica, Smith And Nephew, Solopak, Hikma, Pai Holdings Pharm, Aiping Pharm Inc, Ani Pharms, Chartwell Rx, Dava Pharms Inc, Duramed Pharms Barr, Endo Operations, Impax Labs Inc, Innogenix, Interpharm, Ipca Labs Ltd, Ivax Sub Teva Pharms, Lederle, Mylan, Northstar Hlthcare, Purepac Pharm, Roxane, Sandoz, Schering, Superpharm, Teva, Warner Chilcott, Watson Labs, and Watson Labs Teva. and is included in one hundred and thirty-eight NDAs.
The generic ingredient in PROPRANOLOL HYDROCHLORIDE is hydrochlorothiazide; propranolol hydrochloride. There are thirty-two drug master file entries for this compound. Additional details are available on the hydrochlorothiazide; propranolol hydrochloride profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for PROPRANOLOL HYDROCHLORIDE?
- What are the global sales for PROPRANOLOL HYDROCHLORIDE?
- What is Average Wholesale Price for PROPRANOLOL HYDROCHLORIDE?
Summary for PROPRANOLOL HYDROCHLORIDE
| US Patents: | 0 |
| Applicants: | 41 |
| NDAs: | 138 |
| Finished Product Suppliers / Packagers: | 39 |
| Raw Ingredient (Bulk) Api Vendors: | 156 |
| Clinical Trials: | 338 |
| Patent Litigation and PTAB cases: | See patent lawsuits and PTAB cases for PROPRANOLOL HYDROCHLORIDE |
| What excipients (inactive ingredients) are in PROPRANOLOL HYDROCHLORIDE? | PROPRANOLOL HYDROCHLORIDE excipients list |
| DailyMed Link: | PROPRANOLOL HYDROCHLORIDE at DailyMed |
Recent Clinical Trials for PROPRANOLOL HYDROCHLORIDE
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| AIDS Malignancy Consortium | Phase 2 |
| Zealand University Hospital | Phase 2 |
| Rigshospitalet, Denmark | Phase 2 |
Pharmacology for PROPRANOLOL HYDROCHLORIDE
| Drug Class | beta-Adrenergic Blocker |
| Mechanism of Action | Adrenergic beta-Antagonists |
Medical Subject Heading (MeSH) Categories for PROPRANOLOL HYDROCHLORIDE
Anatomical Therapeutic Chemical (ATC) Classes for PROPRANOLOL HYDROCHLORIDE
Paragraph IV (Patent) Challenges for PROPRANOLOL HYDROCHLORIDE
| Tradename | Dosage | Ingredient | Strength | NDA | ANDAs Submitted | Submissiondate |
|---|---|---|---|---|---|---|
| HEMANGEOL | Oral Solution | propranolol hydrochloride | 4.28 mg/mL | 205410 | 1 | 2022-07-21 |
US Patents and Regulatory Information for PROPRANOLOL HYDROCHLORIDE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Endo Operations | PROPRANOLOL HYDROCHLORIDE | propranolol hydrochloride | TABLET;ORAL | 070221-005 | Sep 24, 1986 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Lederle | PROPRANOLOL HYDROCHLORIDE | propranolol hydrochloride | TABLET;ORAL | 072120-001 | Jun 23, 1988 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Hikma Farmaceutica | PROPRANOLOL HYDROCHLORIDE | propranolol hydrochloride | INJECTABLE;INJECTION | 077760-001 | Jan 31, 2008 | AP | RX | No | Yes | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Upsher Smith Labs | PROPRANOLOL HYDROCHLORIDE | propranolol hydrochloride | CAPSULE, EXTENDED RELEASE;ORAL | 078311-004 | Mar 6, 2009 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Watson Labs Teva | PROPRANOLOL HYDROCHLORIDE | propranolol hydrochloride | TABLET;ORAL | 070550-001 | Apr 11, 1986 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
